A modified E-rosette assay as a semi-empirical tool in search of new T lymphocyte stimulants.

[1]  W. Voelter,et al.  Carboxamidomethyl ester as useful handle in polystyrene-based peptide synthesis: Cleavage of peptide with mercaptide , 1990 .

[2]  A. Bernard,et al.  A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes. , 1988, Journal of immunology.

[3]  R. Bolhuis,et al.  Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. , 1986, Journal of immunology.

[4]  E. Reinherz,et al.  An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein , 1984, Cell.

[5]  O. Martínez-Maza,et al.  Is the E receptor on human T lymphocytes a "negative signal receptor"? , 1982, Journal of immunology.

[6]  J. Weissgarten,et al.  The effect of levamisole on E-rosette formation in the uremic state. , 1982, Thymus.

[7]  T. Ciardelli,et al.  Activity of synthetic thymosin alpha 1 C-terminal peptides in the azathioprine E-rosette inhibition assay. , 1982, Biochemistry.

[8]  M. Fiorilli,et al.  Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. , 1981, Clinical and experimental immunology.

[9]  R. Good,et al.  In vitro differentiation of human marrow cells into T lymphocytes by thymic extracts using the rosette technique. , 1975, Clinical and experimental immunology.

[10]  H. Fudenberg,et al.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. , 1973, The Journal of clinical investigation.

[11]  H H Fudenberg,et al.  The human rosette-forming cell as a marker of a population of thymus-derived cells. , 1972, The Journal of clinical investigation.

[12]  H. Wigzell,et al.  SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES , 1972, The Journal of experimental medicine.